Indian Pharma Market Grows 8.7% in August, Records Rs 20,984 Crore Sales: PharmaTrac
New Delhi: The Indian Pharmaceutical Market (IPM) grew 8.7% in August 2025, reaching Rs 20,984 crore in value, according to the latest PharmaTrac Industry Report by Pharmarack.
In unit terms, the market expanded by 1.2%, underscoring steady demand despite volume stagnation. Growth in August was largely price-driven, supported by new product launches and seasonal therapies.
Therapy-wise, the respiratory segment recorded the strongest growth at 17.3%, driven by seasonal factors. Antineoplastics grew by 19.7%, while urology registered 14.6% growth. Cardiac therapies expanded by 13.2%, and blood-related therapies rose 10% in the month. Anti-diabetic therapies increased by 9.4%, while gastrointestinal products reported 7.1% growth and vitamins and minerals advanced by 5.7%. Neuro/CNS therapies grew by 8.3%, dermatology by 8.7%, and anti-infectives by 8.2%. Vaccines posted a strong rebound, growing 21.4% during the month.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.